Skip to content
Search

Latest Stories

RPS launches professional liability insurance for members

New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.


RPS stated that professional liability insurance, also known as professional indemnity insurance or clinical indemnity, is essential for pharmacists to practice with assurance and provide the highest standard of patient care, regardless of setting, without concerns about potential liability.

The policy covers portfolio careers and prescribing as standard.

The decision to launch the policy follows feedback from RPS members and research conducted by the organisation in 2022.

The findings revealed that over half of the members surveyed had not switched their insurance provider in over a decade, as there are very few options in the market. Additionally, 76% supported the idea of RPS offering professional indemnity insurance.

RPS CEO Paul Bennet said: “The pharmacy landscape is changing rapidly. Advances in practice mean pharmacists are taking on expanded responsibilities to enhance patient care and we are proud to offer this new indemnity policy as part of our commitment to supporting their professional development and confidence.”

“By removing the barriers posed by uncertainty around liability, we aim to enable our members to practise at their full potential.”

“This insurance supports safer practice and reflects our dedication to supporting pharmacists to deliver the highest standard of care for patients."

Mark Riley-Pitt, UK head of health, social care and risk consulting, Aon added: “We have been pleased to collaborate closely with the RPS during the design of this insurance to ensure that it aligns with their members’ needs”.

The insurance will be provided to members at cost, with no profit made by RPS.

Existing RPS members (with some exceptions) will be covered wherever they work, whether or not they are prescribers, but can choose to opt out of the insurance.

New members will be offered the policy as part of their membership package.

This insurance package is not available to non-members.

More For You

Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less